Form 4: Arteris Director S. Atiq Raza Executes Stock Transactions

Director S. Atiq Raza reported a grant of restricted stock units and the subsequent sale of shares held in a family trust.

Summary

• Director S. Atiq Raza received a grant of 4,703 restricted stock units (RSUs) on June 2, 2026.
• The RSUs vest on the earlier of the first anniversary of the grant or the next annual stockholder meeting.
• A total of 20,839 shares were transferred from direct ownership to the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.
• The reporting person sold 20,839 shares held by the trust across multiple transactions on June 3, 2026.
• Sales were executed pursuant to a Rule 10b5-1 trading plan adopted on November 7, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; the transactions are routine insider activity conducted under a pre-planned 10b5-1 arrangement.

Positives

• Director maintains a significant beneficial ownership stake of 140,000 shares following the reported transactions.
• The share sales were conducted under a pre-established 10b5-1 trading plan, indicating systematic rather than reactive selling.

Negatives

• The director reduced his indirect holdings through the sale of 20,839 shares.

Risks

• Future share price volatility may impact the value of remaining holdings.
• Vesting of RSUs is contingent upon continued service to the Board.

Future Outlook

The director continues to hold 140,000 shares, and the RSU grant suggests ongoing commitment to the company through at least the next annual meeting.

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for liquidity and diversification among corporate directors and does not necessarily reflect a negative outlook on company performance.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for corporate insiders to avoid allegations of trading on material non-public information.
• The volume of shares sold is consistent with typical portfolio rebalancing for high-net-worth directors in the semiconductor and software infrastructure space.

Related Party Transactions

• Transfer of 20,839 shares to the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Stakeholder Impact

• Minimal impact expected as the sales were executed via a pre-planned 10b5-1 program.

Next Steps

• Vesting of 4,703 RSUs on the earlier of June 2, 2027, or the next annual stockholder meeting.

Key Dates

Keywords

Arteris, AIP, Insider Trading, Form 4, Director, 10b5-1